Clinical outcomes
Outcomes That Matter.
Peer-reviewed evidence and real-world results showing how proactive monitoring reduces readmissions, lowers costs, and improves access to care.
Peer-reviewed evidence
MedAdept Solutions Deliver Proven Results
A COPD care initiative published in PLOS ONE demonstrated significant reductions in readmissions and healthcare costs.¹
- $1.3M Saved in acute 30-day COPD readmissions
- 71% Reduction in COPD readmissions
- $4.4M Estimated savings in all-cause readmissions
- 85% Reduction in 90-day all-cause readmissions
RTM Significantly Reduces Adverse Events and Costs
$13.45x return — saving $13.45 for every $1 spent by Medicare & MA plans.²*
*Adjusted for patient copays.
A six‑month retrospective analysis of 88 COPD patients showed RTM significantly reduced acute care costs versus U.S. benchmarks.²
Pulmonologist shortages and rising COPD prevalence are driving longer wait times for patient access to care.
- RTM enables faster response to patient alerts through the WatchWell® app.
- RT‑led care navigation and proactive outreach significantly reduced ER visits and hospitalizations.
*Add beneath the ROI section: Based on a retrospective analysis of 88 COPD patients. Results may vary by patient population, payer mix, and implementation.
References
Evidence Sources
Peer-reviewed publication Trout D, Bhansali AH, Riley DD, Peyerl FW, Lee-Chiong TL Jr. A quality improvement initiative for COPD patients: A cost analysis. PLOS ONE. 2020;15(7):e0235040. doi:10.1371/journal.pone.0235040.
Internal outcomes analysis MedAdept, LLC. Retrospective Analysis of Remote Therapeutic Monitoring (RTM) in 88 COPD Patients. Internal outcomes analysis. Unpublished.
Continue the care
See What Proactive Care Can Do.
Let's discuss how these results translate to your populations and care models.
Schedule a Strategic Discussion